Mycobacterium genavense infection in normal and immunodeficient mice

被引:7
作者
Matsiota-Bernard, P
Vildé, F
Nauciel, C [1 ]
机构
[1] Univ Paris 05, Fac Med Paris Ouest, Microbiol Lab, F-92380 Garches, France
[2] Univ Paris 05, Fac Med Necker Enfants Malad, Anat Pathol Lab, Paris, France
关键词
Mycobacterium genavense; mouse;
D O I
10.1016/S1286-4579(00)00369-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycobacterium genavense is a recently described microorganism causing disseminated infections in AIDS patients. In this study, we investigate its pathogenicity in mice and some mechanisms of the host response to this bacterium. Following an intravenous challenge of 10(6) organisms, M. genavense grew progressively in the spleens and livers of BALB/c and CBA mice over at least an 8-month period. Granulomas were present in the spleens, livers and lungs of the animals. The numbers of bacteria recovered from the spleens and livers were higher in BALB/c (Bcg(s)) than in CBA (Bcg(r)) mice from day 30. The role of the Bcg gene, in the early phase of infection, was supported by the fact that the bacterial load, on day 15, was higher in BALB/c than in the congenic C.D2 (Bcg(r)) mice. The role of T cells in die host response was suggested by the high susceptibility of nude mice to M. genavense infection. In vivo depletion experiments in CBA mice indicated that gamma interferon and both CD4(+) and CD8(+) T cells participate in the containment of the bacterial load. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:575 / 580
页数:6
相关论文
共 23 条
[1]   ROLE OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA DURING T-CELL-INDEPENDENT AND T-CELL-DEPENDENT PHASES OF MYCOBACTERIUM-AVIUM INFECTION [J].
APPELBERG, R ;
CASTRO, AG ;
PEDROSA, J ;
SILVA, RA ;
ORME, IM ;
MINOPRIO, P .
INFECTION AND IMMUNITY, 1994, 62 (09) :3962-3971
[2]   INFECTION WITH MYCOBACTERIUM-AVIUM INDUCES PRODUCTION OF INTERLEUKIN-10 (IL-10), AND ADMINISTRATION OF ANTI-IL-10 ANTIBODY IS ASSOCIATED WITH ENHANCED RESISTANCE TO INFECTION IN MICE [J].
BERMUDEZ, LE ;
CHAMPSI, J .
INFECTION AND IMMUNITY, 1993, 61 (07) :3093-3097
[3]   DISSEMINATED MYCOBACTERIUM-GENAVENSE INFECTION - CLINICAL AND MICROBIOLOGICAL FEATURES AND RESPONSE TO THERAPY [J].
BESSESEN, MT ;
SHLAY, J ;
STONEVENOHR, B ;
COHN, DL ;
REVES, RR .
AIDS, 1993, 7 (10) :1357-1361
[4]   Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus [J].
Bogdan, C ;
Kern, P ;
Richter, E ;
Tannapfel, A ;
RuschGerdes, S ;
Kirchner, T ;
Solbach, W .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1245-1247
[5]   MYCOBACTERIUM GENAVENSE - AN EMERGING PATHOGEN [J].
BOTTGER, EC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (11) :932-936
[6]   DISSEMINATED MYCOBACTERIUM-GENAVENSE INFECTION IN PATIENTS WITH AIDS [J].
BOTTGER, EC ;
TESKE, A ;
KIRSCHNER, P ;
BOST, S ;
CHANG, HR ;
BEER, V ;
HIRSCHEL, B .
LANCET, 1992, 340 (8811) :76-80
[7]   THE PROTECTIVE IMMUNE-RESPONSE TO MYCOBACTERIUM-TUBERCULOSIS [J].
COOPER, AM ;
FLYNN, JL .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) :512-516
[8]  
DENIS M, 1993, J IMMUNOL, V151, P5425
[9]   SPECIES-SPECIFIC MYCOBACTERIUM GENAVENSE DNA IN INTESTINAL TISSUES OF INDIVIDUALS NOT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DUMONCEAU, JM ;
FONTEYNE, PA ;
REALINI, L ;
VANGOSSUM, A ;
VANVOOREN, JP ;
PORTAELS, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (09) :2514-2515
[10]   FATAL INFECTION WITH A NOVEL, UNIDENTIFIED MYCOBACTERIUM IN A MAN WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
HIRSCHEL, B ;
CHANG, HR ;
MACH, N ;
PIGUET, PF ;
COX, J ;
PIGUET, JD ;
SILVA, MT ;
LARSSON, L ;
KLATSER, PR ;
THOLE, JER ;
RIGOUTS, L ;
PORTAELS, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (02) :109-113